目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Has there been any recent developments in the market?

8 Company Profiles
8.1. Takeda Pharmaceutical Company Limited
8.2. Astellas Pharma Inc.
8.3. Daiichi Sankyo Co Ltd
8.4. Mitsubishi Tanabe Pharma Corporation

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Japan biotechnology industry value: $ billion, 2017-22
Table 2: Japan biotechnology industry category segmentation: % share, by value, 2017-2022
Table 3: Japan biotechnology industry category segmentation: $ billion, 2017-2022
Table 4: Japan biotechnology industry geography segmentation: $ billion, 2022
Table 5: Japan biotechnology industry value forecast: $ billion, 2022-27
Table 6: Takeda Pharmaceutical Company Limited: key facts
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Astellas Pharma Inc.: key facts
Table 11: Astellas Pharma Inc.: Annual Financial Ratios
Table 12: Astellas Pharma Inc.: Key Employees
Table 13: Daiichi Sankyo Co Ltd: key facts
Table 14: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 15: Daiichi Sankyo Co Ltd: Key Employees
Table 16: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 17: Mitsubishi Tanabe Pharma Corporation: key facts
Table 18: Japan size of population (million), 2018-22
Table 19: Japan gdp (constant 2005 prices, $ billion), 2018-22
Table 20: Japan gdp (current prices, $ billion), 2018-22
Table 21: Japan inflation, 2018-22
Table 22: Japan consumer price index (absolute), 2018-22
Table 23: Japan exchange rate, 2018-22

List of Figures
Figure 1: Japan biotechnology industry value: $ billion, 2017-22
Figure 2: Japan biotechnology industry category segmentation: $ billion, 2017-2022
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2022
Figure 4: Japan biotechnology industry value forecast: $ billion, 2022-27
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2022
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2022
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2022
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2022
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2022
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2022